CLEVER CULTURE SYSTEMS LIMITED - Announcements

2.86%

3.6¢

Market Cap $65.33M

Healthcare Biotechnology

Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based... Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based company that provides intelligent automation solutions to microbiology laboratories. The Company has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence (AI) and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates. The technology is a United States FDA-cleared AI technology for automated culture plate reading. The product is being sold to microbiology laboratories in the pharmaceutical manufacturing sector for the reading of environmental monitoring culture plates and to clinical laboratories as an in vitro diagnostic for infectious diseases. Thermo Fisher Scientific, Inc is the exclusive distributor of the APAS Independence to clinical customers in the United States and selected countries in Europe.More

Announcements

Filter Results

All Price Sensitive Only

CC5	Initial Director's Interest Notice-LBT.AX		09/08/16	99.64KB	Share
CC5	Final Director's Interest Notice-LBT.AX		09/08/16	97.73KB	Share
CC5	Appendix 4C - quarterly-LBT.AX	PRICE SENSITIVE	29/07/16	132.11KB	Share
CC5	Retiring LBT CEO Lusia Guthrie Appointed Chair of CCS AG-LBT.AX		10/06/16	118.14KB	Share
CC5	LBT granted patent in Japan for core APAS technology-LBT.AX	PRICE SENSITIVE	19/05/16	95.51KB	Share
CC5	Cochlear Executive Brent Barnes Appointed CEO of LBT-LBT.AX	PRICE SENSITIVE	09/05/16	118.17KB	Share
CC5	Appendix 3B-LBT.AX		09/05/16	558.22KB	Share
CC5	Appendix 4C - quarterly-LBT.AX	PRICE SENSITIVE	26/04/16	324.36KB	Share
CC5	LBT Receives Notice of Allowance for Third Patent-LBT.AX	PRICE SENSITIVE	07/04/16	114.53KB	Share
CC5	Change of Director's Interest Notice		11/03/16	234.66KB	Share
CC5	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/16	511.39KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	430.6KB	Share
CC5	LBT Innovations Completes U.S. Regulatory Submission	PRICE SENSITIVE	22/12/15	108.57KB	Share
CC5	LBT Concludes APAS Clinical Trial Program	PRICE SENSITIVE	16/11/15	106.1KB	Share
CC5	Appendix 3B		09/11/15	561.08KB	Share
CC5	Results of Meeting		21/10/15	108.39KB	Share
CC5	AGM 2015 CEO Presentation		21/10/15	1.11MB	Share
CC5	Chairman's Address to Shareholders		21/10/15	141.7KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	20/10/15	345.88KB	Share
CC5	LBT Receives Notice of Allowance for Second Patent	PRICE SENSITIVE	14/10/15	105.14KB	Share
CC5	LBT CEO Retirement	PRICE SENSITIVE	12/10/15	160.19KB	Share
CC5	APAS Exceeds Expectations in Key U.S. Clinical Trials	PRICE SENSITIVE	07/10/15	241.63KB	Share
CC5	Appendix 4G		25/09/15	744.2KB	Share
CC5	Annual Report to shareholders		25/09/15	2.95MB	Share
CC5	Notice of Annual General Meeting/Proxy Form		18/09/15	383.54KB	Share
CC5	Resubmission of 3Y - 17 September 2015		18/09/15	426.71KB	Share
CC5	Change of Director's Interest Notice		18/09/15	236.25KB	Share
CC5	Change of Director's Interest Notice		17/09/15	356.78KB	Share
CC5	Change of Director's Interest Notice		04/09/15	236.18KB	Share
CC5	Change of Director's Interest Notice		01/09/15	232.64KB	Share
CC5	LBT Innovations Market Update	PRICE SENSITIVE	28/08/15	188.76KB	Share
CC5	Preliminary Final Report	PRICE SENSITIVE	27/08/15	570.98KB	Share
CC5	LBT Signs Agreement with bioMerieux	PRICE SENSITIVE	27/08/15	189.48KB	Share
CC5	Change in substantial holding		31/07/15	76.42KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15	167.67KB	Share
CC5	Change in substantial holding		30/07/15	965.51KB	Share
CC5	LBT begins key U.S. trial of APAS technology	PRICE SENSITIVE	09/06/15	182.95KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/15	132.39KB	Share
CC5	Shareholder News - April 2015		30/03/15	6.21MB	Share
CC5	LBT Granted First U.S. Patent for APAS Technology	PRICE SENSITIVE	26/03/15	84.82KB	Share
CC5	Appendix 4D	PRICE SENSITIVE	27/02/15	4.11MB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	282.9KB	Share
CC5	Notice of Intent re PREVI Isola Licence Agreement	PRICE SENSITIVE	12/01/15	166.98KB	Share
CC5	CEO Presentation at Ausbiotech Biotech Invest Summit		03/12/14	1.11MB	Share
CC5	LBT Completes Australian Clinical Trials of APAS Technology	PRICE SENSITIVE	26/11/14	105.42KB	Share
CC5	Change of Company Secretary		20/11/14	89.52KB	Share
CC5	Results of Meeting		28/10/14	105.76KB	Share
CC5	AGM CEO Presentation		28/10/14	2.56MB	Share
CC5	Chairman's Address to Shareholders		28/10/14	116.82KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	24/10/14	89.08KB	Share
CC5	LBT Awarded $250,000 Grant for Woundvue	PRICE SENSITIVE	20/10/14	119.32KB	Share
CC5	Change of Director's Interest Notice		13/10/14	114.19KB	Share
CC5	Notice of Annual General Meeting/Proxy Form		19/09/14	550.86KB	Share
CC5	Annual Report to shareholders		19/09/14	2.06MB	Share
CC5	LBT Begins Clinical Trials of APAS Technology	PRICE SENSITIVE	19/09/14	104.52KB	Share
CC5	LBT Innovations receives $3M 2014 R&D tax incentive	PRICE SENSITIVE	04/09/14	124.61KB	Share
CC5	Appendix 4E	PRICE SENSITIVE	29/08/14	144.13KB	Share
CC5	LBT Innovations Appoints Chief Financial Officer		28/08/14	35.89KB	Share
CC5	LBT APPOINTS US-BASED CLINICAL TRIAL CO-ORDINATOR		25/08/14	36.78KB	Share
CC5	Despatch of SPP and Tranche 2 Holding Statements		13/08/14	193.15KB	Share
CC5	Notice of initial substantial holder		12/08/14	726.45KB	Share
CC5	Placement - Cleansing Notice		07/08/14	96.02KB	Share
CC5	Change of Director's Interest Notice		07/08/14	233.45KB	Share
CC5	Change of Director's Interest Notice		07/08/14	249.49KB	Share
CC5	Change of Director's Interest Notice		07/08/14	235.8KB	Share
CC5	Appendix 3B		07/08/14	558.46KB	Share
CC5	Change of Director's Interest Notice		07/08/14	249.18KB	Share
CC5	Appendix 3B		07/08/14	551.36KB	Share
CC5	Office Relocation		06/08/14	105.1KB	Share
CC5	Results of EGM		01/08/14	444.92KB	Share
CC5	Chairman's Address to Shareholders		01/08/14	35.85KB	Share
CC5	Appendix 4C - quarterly report	PRICE SENSITIVE	31/07/14	90.43KB	Share
CC5	Completion of Share Purchase Plan Raising		25/07/14	79.63KB	Share
CC5	LBT Innovations Presents Results of Most Extensive Study		07/07/14	97.34KB	Share
CC5	Despatch of Share Purchase Plan Offer Documents		27/06/14	734.42KB	Share
CC5	Placement - Tranche 1 Cleansing Notice		25/06/14	100.17KB	Share
CC5	Appendix 3B		25/06/14	598.99KB	Share
CC5	LBT raises A$1.5M in private placement	PRICE SENSITIVE	18/06/14	143.24KB	Share
CC5	Trading Halt	PRICE SENSITIVE	16/06/14	126.29KB	Share
CC5	LBT Innovations receives third $1M milestone payment	PRICE SENSITIVE	11/06/14	100.64KB	Share
CC5	Updated Investor and Shareholder Presentation		13/05/14	1.28MB	Share
CC5	Investor and Shareholder Presentation		12/05/14	2.12MB	Share
CC5	LBT Innovations Introduces Landmark Diagnostic Platform	PRICE SENSITIVE	12/05/14	123.53KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/14	1.03MB	Share
CC5	Response to Price Query	PRICE SENSITIVE	10/04/14	105.39KB	Share
CC5	Change of Director's Interest Notice		18/03/14	352.89KB	Share
CC5	Change of Director's Interest Notice		11/03/14	358.49KB	Share
CC5	Appendix 4D Half Year Results	PRICE SENSITIVE	20/02/14	1.17MB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/14	346.52KB	Share
CC5	Appendix 3B		11/12/13	1.47MB	Share
CC5	Appendix 3B		09/12/13	2.25MB	Share
CC5	Change of Director's Interest Notice		05/12/13	93.46KB	Share
CC5	Results of Meeting		26/11/13	140.33KB	Share
CC5	AGM CEO Presentation		26/11/13	9.74MB	Share
CC5	Chairman's Address to Shareholders		26/11/13	331.46KB	Share
CC5	Notice of Annual General Meeting/Proxy Form		22/10/13	476.47KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	17/10/13	1MB	Share
CC5	Annual Report to shareholders		27/09/13	3.9MB	Share
CC5	Preliminary Final Report	PRICE SENSITIVE	21/08/13	309.24KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	26/07/13	427.33KB	Share

CC5 Initial Director's Interest Notice-LBT.AX
09/08/16		99.64KB	Share
CC5 Final Director's Interest Notice-LBT.AX
09/08/16		97.73KB	Share
CC5 Appendix 4C - quarterly-LBT.AX
29/07/16	PRICE SENSITIVE	132.11KB	Share
CC5 Retiring LBT CEO Lusia Guthrie Appointed Chair of CCS AG-LBT.AX
10/06/16		118.14KB	Share
CC5 LBT granted patent in Japan for core APAS technology-LBT.AX
19/05/16	PRICE SENSITIVE	95.51KB	Share
CC5 Cochlear Executive Brent Barnes Appointed CEO of LBT-LBT.AX
09/05/16	PRICE SENSITIVE	118.17KB	Share
CC5 Appendix 3B-LBT.AX
09/05/16		558.22KB	Share
CC5 Appendix 4C - quarterly-LBT.AX
26/04/16	PRICE SENSITIVE	324.36KB	Share
CC5 LBT Receives Notice of Allowance for Third Patent-LBT.AX
07/04/16	PRICE SENSITIVE	114.53KB	Share
CC5 Change of Director's Interest Notice
11/03/16		234.66KB	Share
CC5 Half Yearly Report and Accounts
29/02/16	PRICE SENSITIVE	511.39KB	Share
CC5 Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	430.6KB	Share
CC5 LBT Innovations Completes U.S. Regulatory Submission
22/12/15	PRICE SENSITIVE	108.57KB	Share
CC5 LBT Concludes APAS Clinical Trial Program
16/11/15	PRICE SENSITIVE	106.1KB	Share
CC5 Appendix 3B
09/11/15		561.08KB	Share
CC5 Results of Meeting
21/10/15		108.39KB	Share
CC5 AGM 2015 CEO Presentation
21/10/15		1.11MB	Share
CC5 Chairman's Address to Shareholders
21/10/15		141.7KB	Share
CC5 Appendix 4C - quarterly
20/10/15	PRICE SENSITIVE	345.88KB	Share
CC5 LBT Receives Notice of Allowance for Second Patent
14/10/15	PRICE SENSITIVE	105.14KB	Share
CC5 LBT CEO Retirement
12/10/15	PRICE SENSITIVE	160.19KB	Share
CC5 APAS Exceeds Expectations in Key U.S. Clinical Trials
07/10/15	PRICE SENSITIVE	241.63KB	Share
CC5 Appendix 4G
25/09/15		744.2KB	Share
CC5 Annual Report to shareholders
25/09/15		2.95MB	Share
CC5 Notice of Annual General Meeting/Proxy Form
18/09/15		383.54KB	Share
CC5 Resubmission of 3Y - 17 September 2015
18/09/15		426.71KB	Share
CC5 Change of Director's Interest Notice
18/09/15		236.25KB	Share
CC5 Change of Director's Interest Notice
17/09/15		356.78KB	Share
CC5 Change of Director's Interest Notice
04/09/15		236.18KB	Share
CC5 Change of Director's Interest Notice
01/09/15		232.64KB	Share
CC5 LBT Innovations Market Update
28/08/15	PRICE SENSITIVE	188.76KB	Share
CC5 Preliminary Final Report
27/08/15	PRICE SENSITIVE	570.98KB	Share
CC5 LBT Signs Agreement with bioMerieux
27/08/15	PRICE SENSITIVE	189.48KB	Share
CC5 Change in substantial holding
31/07/15		76.42KB	Share
CC5 Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE	167.67KB	Share
CC5 Change in substantial holding
30/07/15		965.51KB	Share
CC5 LBT begins key U.S. trial of APAS technology
09/06/15	PRICE SENSITIVE	182.95KB	Share
CC5 Appendix 4C - quarterly
28/04/15	PRICE SENSITIVE	132.39KB	Share
CC5 Shareholder News - April 2015
30/03/15		6.21MB	Share
CC5 LBT Granted First U.S. Patent for APAS Technology
26/03/15	PRICE SENSITIVE	84.82KB	Share
CC5 Appendix 4D
27/02/15	PRICE SENSITIVE	4.11MB	Share
CC5 Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	282.9KB	Share
CC5 Notice of Intent re PREVI Isola Licence Agreement
12/01/15	PRICE SENSITIVE	166.98KB	Share
CC5 CEO Presentation at Ausbiotech Biotech Invest Summit
03/12/14		1.11MB	Share
CC5 LBT Completes Australian Clinical Trials of APAS Technology
26/11/14	PRICE SENSITIVE	105.42KB	Share
CC5 Change of Company Secretary
20/11/14		89.52KB	Share
CC5 Results of Meeting
28/10/14		105.76KB	Share
CC5 AGM CEO Presentation
28/10/14		2.56MB	Share
CC5 Chairman's Address to Shareholders
28/10/14		116.82KB	Share
CC5 Appendix 4C - quarterly
24/10/14	PRICE SENSITIVE	89.08KB	Share
CC5 LBT Awarded $250,000 Grant for Woundvue
20/10/14	PRICE SENSITIVE	119.32KB	Share
CC5 Change of Director's Interest Notice
13/10/14		114.19KB	Share
CC5 Notice of Annual General Meeting/Proxy Form
19/09/14		550.86KB	Share
CC5 Annual Report to shareholders
19/09/14		2.06MB	Share
CC5 LBT Begins Clinical Trials of APAS Technology
19/09/14	PRICE SENSITIVE	104.52KB	Share
CC5 LBT Innovations receives $3M 2014 R&D tax incentive
04/09/14	PRICE SENSITIVE	124.61KB	Share
CC5 Appendix 4E
29/08/14	PRICE SENSITIVE	144.13KB	Share
CC5 LBT Innovations Appoints Chief Financial Officer
28/08/14		35.89KB	Share
CC5 LBT APPOINTS US-BASED CLINICAL TRIAL CO-ORDINATOR
25/08/14		36.78KB	Share
CC5 Despatch of SPP and Tranche 2 Holding Statements
13/08/14		193.15KB	Share
CC5 Notice of initial substantial holder
12/08/14		726.45KB	Share
CC5 Placement - Cleansing Notice
07/08/14		96.02KB	Share
CC5 Change of Director's Interest Notice
07/08/14		233.45KB	Share
CC5 Change of Director's Interest Notice
07/08/14		249.49KB	Share
CC5 Change of Director's Interest Notice
07/08/14		235.8KB	Share
CC5 Appendix 3B
07/08/14		558.46KB	Share
CC5 Change of Director's Interest Notice
07/08/14		249.18KB	Share
CC5 Appendix 3B
07/08/14		551.36KB	Share
CC5 Office Relocation
06/08/14		105.1KB	Share
CC5 Results of EGM
01/08/14		444.92KB	Share
CC5 Chairman's Address to Shareholders
01/08/14		35.85KB	Share
CC5 Appendix 4C - quarterly report
31/07/14	PRICE SENSITIVE	90.43KB	Share
CC5 Completion of Share Purchase Plan Raising
25/07/14		79.63KB	Share
CC5 LBT Innovations Presents Results of Most Extensive Study
07/07/14		97.34KB	Share
CC5 Despatch of Share Purchase Plan Offer Documents
27/06/14		734.42KB	Share
CC5 Placement - Tranche 1 Cleansing Notice
25/06/14		100.17KB	Share
CC5 Appendix 3B
25/06/14		598.99KB	Share
CC5 LBT raises A$1.5M in private placement
18/06/14	PRICE SENSITIVE	143.24KB	Share
CC5 Trading Halt
16/06/14	PRICE SENSITIVE	126.29KB	Share
CC5 LBT Innovations receives third $1M milestone payment
11/06/14	PRICE SENSITIVE	100.64KB	Share
CC5Updated Investor and Shareholder Presentation
13/05/14		1.28MB	Share
CC5Investor and Shareholder Presentation
12/05/14		2.12MB	Share
CC5LBT Innovations Introduces Landmark Diagnostic Platform
12/05/14	PRICE SENSITIVE	123.53KB	Share
CC5Appendix 4C - quarterly
28/04/14	PRICE SENSITIVE	1.03MB	Share
CC5Response to Price Query
10/04/14	PRICE SENSITIVE	105.39KB	Share
CC5Change of Director's Interest Notice
18/03/14		352.89KB	Share
CC5Change of Director's Interest Notice
11/03/14		358.49KB	Share
CC5Appendix 4D Half Year Results
20/02/14	PRICE SENSITIVE	1.17MB	Share
CC5Appendix 4C - quarterly
31/01/14	PRICE SENSITIVE	346.52KB	Share
CC5Appendix 3B
11/12/13		1.47MB	Share
CC5Appendix 3B
09/12/13		2.25MB	Share
CC5Change of Director's Interest Notice
05/12/13		93.46KB	Share
CC5Results of Meeting
26/11/13		140.33KB	Share
CC5AGM CEO Presentation
26/11/13		9.74MB	Share
CC5Chairman's Address to Shareholders
26/11/13		331.46KB	Share
CC5Notice of Annual General Meeting/Proxy Form
22/10/13		476.47KB	Share
CC5Appendix 4C - quarterly
17/10/13	PRICE SENSITIVE	1MB	Share
CC5Annual Report to shareholders
27/09/13		3.9MB	Share
CC5Preliminary Final Report
21/08/13	PRICE SENSITIVE	309.24KB	Share
CC5Appendix 4C - quarterly
26/07/13	PRICE SENSITIVE	427.33KB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.6¢		Change 0.001(2.86%)		Mkt cap ! $65.33M

Open	High	Low	Value	Volume
3.5¢	3.6¢	3.5¢	$18.02K	513.3K

Buyers (Bids)

No.	Vol.	Price($)
7	991682	3.4¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	1072927	5

View Market Depth

No.	Vol.	Price($)
7	991682	0.034
6	971865	0.033
4	504275	0.032
1	32258	0.031
4	618150	0.030

Price($)	Vol.	No.
0.036	1072927	5
0.037	1353817	1
0.039	1128436	4
0.040	3000000	2
0.041	300000	1

Last trade - 15.55pm 21/08/2025 (20 minute delay)


Last 3.6¢		Change 0.001 ( 2.86 %)
Open	High	Low	Volume
3.5¢	3.6¢	3.5¢	84104
Last updated 15.55pm 21/08/2025 ?

CC5 (ASX) Chart

CLEVER CULTURE SYSTEMS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories